Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer — Αngeliki Andrikopoulou (2023) | RDL Network
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
Article 2023 en
Authors
ΑA
Αngeliki Andrikopoulou
CT
Charalampos Theofanakis
CM
Christos Markellos
Abstract
1 min read
We have demonstrated that performing IDS within four weeks after NACT may be associated with better survival outcomes. Multidisciplinary coordination among ovarian cancer patients is required to avoid any unnecessary delays.
Maria Kaparelou, Roubini Zakopoulou, Anna Tsiara, Anastasios Kyriazoglou, Michalis Liontos, G. P. Tsironis, K. Koutsoukos, Flora Zagouri, Dimitrios‐Efthymios Vlachos, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios A Dimopoulos, Aristotle Bamias
M. Liontos, A. Andrikopoulou, Konstantinos Koutsoukos, Christos Markellos, Efi Skafida, Oraianthi Fiste, Maria Kaparelou, N. Thomakos, Dimitrios Haidopoulos, A. Rodolakis, Meletios A Dimopoulos, Flora Zagouri
Discussion(0)
No comments yet. Be the first to comment.